Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

25.46
Delayed Data
As of May 04
 -0.23 / -0.90%
Today’s Change
24.83
Today|||52-Week Range
43.63
-40.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues305.8M336.4M401.5M492.7M
 
 
 
 
 
Cost of Goods Sold53.0M59.6M72.1M77.9M
 
 
 
 
 
Depreciation And Amortization4.7M7.0M8.5M15.0M
 
 
 
 
 
 
Operating ExpensesGross Income248.2M269.8M320.9M399.7M
 
 
 
 
 
General Expenses222.6M238.6M268.5M354.8M
 
 
 
 
 
Research And Development53.9M53.9M73.5M149.2M
 
 
 
 
 
Total Operating Expenses280.2M305.2M349.1M447.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income25.6M31.2M52.4M44.9M
 
 
 
 
 
Extraordinary Credit0.00182.0K236.0K0.00
 
 
 
Extraordinary Charge-664.0K-1.0M-16.4M-10.9M
 
 
 
 
 
Interest Expense On Debt1.9M2.2M9.3M15.5M
 
 
 
 
 
Other Expenses695.0K0.00379.0K411.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income24.3M28.9M28.0M19.4M
 
 
 
 
 
Income Taxes-130.7M-12.4M-10.3M-8.3M
 
 
 
 
 
Net Income155.0M16.4M17.7M11.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS39.5M40.2M41.2M42.2M
 
 
 
 
 
Shares To Calculate EPS Diluted40.3M41.7M42.5M43.6M
 
 
 
 
 
 
Earnings Per ShareEPS$3.84$0.39$0.42$0.25
 
 
 
 
 
EPS Diluted$3.84$0.39$0.42$0.25